Which of the following must be included on the label for IV admixtures?

The correct choice, which highlights the necessity of including cautionary statements on the label for intravenous (IV) admixtures, is rooted in ensuring patient safety and promoting appropriate use of the medication. Cautionary statements provide essential information regarding potential risks, side effects, or specific administration considerations that healthcare providers and caregivers need to be aware of. This information can help prevent adverse reactions and promote proper handling of the admixture.

Including cautionary statements is a regulatory requirement and is fundamental to pharmaceutical practice, as it ensures that all individuals involved in the administration of the IV admixture are adequately informed about any specific precautions that should be taken. This emphasis on safety reflects the overall goal of pharmaceutical care, which is to ensure that medications are used properly and effectively while minimizing potential harm to patients.

While aspects like the duration of therapy, patient's contact information, and the pharmacy's location may be relevant for record-keeping or communication purposes, they are not universally required elements on the label of IV admixtures. The focus on cautionary statements underscores the critical role that clear labeling plays in the safe administration of intravenous medications.